Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.80
-0.11
(-1.39%)
USD |
NASDAQ |
May 27, 16:00
7.80
0.00 (0.00%)
After-Hours: 17:08
Corbus Pharmaceuticals Holdings EPS Diluted (Quarterly) : -1.228 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
| Plus Therapeutics, Inc. | -1.045 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | 1.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.97M |
| Total Expenses (Quarterly) | 22.97M |
| Enterprise Value | 9.156M |
| Earnings Yield | -74.54% |
| Normalized Earnings Yield | -74.54 |